We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » British Drugmakers See Progress in Lupus Trials
Two British pharmaceutical giants saw positive results in studies of their respective lupus candidates, a rare show of progress for the underfunded condition with few care options and even fewer innovations.